This study is evaluating Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to create a "map" of each breast. Researchers want to see if Feminai can help identify suspicious areas that might need further medical checks. The study aims to enroll up to 300 women, aged 25-75, who are already getting breast cancer screenings. Feminai results will be compared to mammograms and, if applicable, biopsy results to see how well it detects suspicious lesions and how accurately it rules them out. Feminai is meant to support doctors' decisions and does not replace standard diagnostic tests. The study's success will be measured by how accurately Feminai identifies (sensitivity) and rules out (negative predictive value) suspicious lesions.

Study design

This is an observational study involving up to 300 women. It is not specified if it is randomized or blinded.

What's involved

You would have one study visit where trained staff apply the Feminai patch to your breasts and you complete a short questionnaire.

Compensation

Not stated in the trial record.

Follow-up

You would be followed for up to 6 months after enrollment to compare Feminai results with mammography and biopsy results.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.